Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gottfried-Anacker, J.
Right arrow Articles by Janzowski, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottfried-Anacker, J.
Right arrow Articles by Janzowski, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1985 Oxford University Press

research-article

Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and {omega}-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat

J. Gottfried-Anacker 1, R. Preussmann 1, G. Eisenbrand 2 and C. Janzowski 2 3

1Institute of Toxicology and Chemotherapy, German Cancer Research Center Im Neuenheimer Feld 280, D-6900 Heidelberg
2Department of Food Chemistry and Environmental Toxicology, University of Kaiserslautern D-6750 Kaiserslautern, FRG

3To whom reprint requests should be sent

Urinary excretion of N-nitrosodibutylamine (NDBA) and of two {omega}-fluorinated analogues [N-nitroso-4, 4, 4-trifluorobutyl-butylamine, NDBA-F3; N-nitroso-bis(4, 4, 4-trifluorobutyl)-amine, NDBA-F6] was studied in male Sprague-Dawley (SD) rats. After oral application of equimolar doses (0.44 and 1.32 mmol/kg body wt.) urines were collected (48 h) and analyzed for parent compounds, and for nitrosamine metabolites by gas chromatography/Thermal Energy Analyzer (GC/TEA) and gas chromatography/mass spectrometry (GC/MS). After administration of NDBA the known major metabolites N-nitroso-3- hydroxybutylbutylamine (3-OH-NDBA) and N-nitroso-3-carboxypropylbutylamine (BCPN) were excreted in urine. After application of the {omega}-fluorinated analogue NDBA-F6, however, urinary and biliary nitrosamine metabolites were detected only in trace amounts. This finding demonstrates a strong inhibitory effect of fluorine substitution on oxidations at {omega}, ({omega}-1) and ß-positions. Confirmation of this inhibitory effect of {omega}-fluorine substitution is given from the excretion profiles of NDBA-F3 which shows metabolic oxidations only at the nonfluorinated chain: N-nitroso-3-hydroxybutyl-4, 4, 4,-trifluorobutylamine (3-OH-NDBA-F3) and N-nitroso-3-carboxypropyl-4, 4, 4-trifluoro-butylamine (BCPN-F3) were excreted as main metabolites. Our results on metabolism together with the available data on carcinogenicity of the compounds in the rat strongly support the hypothesis that {omega}-oxidation of one butyl-chain is a prerequisite for the induction of urinary bladder tumors with NDBA. For the induction of liver tumors, {alpha}-C-hydroxylation appears to be the crucial event.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.